BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19939895)

  • 1. Age at diagnosis and age at death in familial prostate cancer.
    Brandt A; Bermejo JL; Sundquist J; Hemminki K
    Oncologist; 2009 Dec; 14(12):1209-17. PubMed ID: 19939895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age specific and attributable risks of familial prostate carcinoma from the family-cancer database.
    Hemminki K; Czene K
    Cancer; 2002 Sep; 95(6):1346-53. PubMed ID: 12216104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial risks of breast and prostate cancers: does the definition of the at risk period matter?
    Brandt A; Bermejo JL; Sundquist J; Hemminki K
    Eur J Cancer; 2010 Mar; 46(4):752-7. PubMed ID: 20022238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age specific risks of familial prostate carcinoma: a basis for screening recommendations in high risk populations.
    Grönberg H; Wiklund F; Damber JE
    Cancer; 1999 Aug; 86(3):477-83. PubMed ID: 10430256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial prostate cancer in Sweden. A nationwide register cohort study.
    Grönberg H; Damber L; Damber JE
    Cancer; 1996 Jan; 77(1):138-43. PubMed ID: 8630920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of prostate-specific antigen testing on familial prostate cancer risk estimates.
    Bratt O; Garmo H; Adolfsson J; Bill-Axelson A; Holmberg L; Lambe M; Stattin P
    J Natl Cancer Inst; 2010 Sep; 102(17):1336-43. PubMed ID: 20724726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher frequency of familial clustering of prostate cancer in French-Canadian men.
    Filion E; Taussky D; Bahary JP; Maugard CM
    J Urol; 2007 Oct; 178(4 Pt 1):1265-9; discussion 1270. PubMed ID: 17698103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary aspects of prostate cancer.
    McLellan DL; Norman RW
    CMAJ; 1995 Oct; 153(7):895-900. PubMed ID: 7553490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial risk of cancer shortly after diagnosis of the first familial tumor.
    Bermejo JL; Hemminki K
    J Natl Cancer Inst; 2005 Nov; 97(21):1575-9. PubMed ID: 16264177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic, epidemiologic and clinical study of familial prostate cancer].
    Valéri A
    Bull Acad Natl Med; 2002; 186(4):779-88; discussion 788-91. PubMed ID: 12412374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis.
    Zeegers MP; Jellema A; Ostrer H
    Cancer; 2003 Apr; 97(8):1894-903. PubMed ID: 12673715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
    Leu M; Reilly M; Czene K
    J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial aspects of prostate cancer: a case control study.
    Keetch DW; Rice JP; Suarez BK; Catalona WJ
    J Urol; 1995 Dec; 154(6):2100-2. PubMed ID: 7500468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of familial breast cancer in sisters.
    Rebora P; Czene K; Reilly M
    J Natl Cancer Inst; 2008 May; 100(10):721-7. PubMed ID: 18477799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk perception and concern among brothers of men with prostate carcinoma.
    Beebe-Dimmer JL; Wood DP; Gruber SB; Chilson DM; Zuhlke KA; Claeys GB; Cooney KA
    Cancer; 2004 Apr; 100(7):1537-44. PubMed ID: 15042690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology of familial prostatic cancer: 4-year assessment of French studies].
    Valeri A; Drelon E; Azzouzi R; Delannoy A; Teillac P; Fournier G; Mangin P; Berthon P; Cussenot O
    Prog Urol; 1999 Sep; 9(4):672-9. PubMed ID: 10555220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age.
    Sweat SD; Bergstralh EJ; Slezak J; Blute ML; Zincke H
    J Urol; 2002 Aug; 168(2):525-9. PubMed ID: 12131302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early onset prostate cancer: predictors of clinical grade.
    Kotsis SV; Spencer SL; Peyser PA; Montie JE; Cooney KA
    J Urol; 2002 Apr; 167(4):1659-63. PubMed ID: 11912383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer risk with positive family history, normal prostate examination findings, and PSA less than 4.0 ng/mL.
    Canby-Hagino E; Hernandez J; Brand TC; Troyer DA; Higgins B; Ankerst DP; Thompson IM; Leach RJ; Parekh DJ
    Urology; 2007 Oct; 70(4):748-52. PubMed ID: 17991549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.